We are live on ! Find out more
AP

Arlington Partners Portfolio holdings

AUM $55.4M
1-Year Est. Return 8%
This Fund
S&P 500
This Quarter Est. Return
+7.5%
1 Year Est. Return
+8%
3 Year Est. Return
+43.69%
5 Year Est. Return
+33.63%
10 Year Est. Return
AUM
$196M
AUM Growth
-$151M
Cap. Flow
-$164M
Cap. Flow %
-83.5%
Top 10 Hldgs %
26.93%
Holding
261
New
5
Increased
22
Reduced
26
Closed
201

Sector Composition

Rank Sector Weight
1 Financials 21.99%
2 Healthcare 15.86%
3 Technology 15.23%
4 Industrials 12.64%
5 Communication Services 11.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$343B
$3.22M 1.64%
19,875
-845
-4% -$133K
IFF icon
27
International Flavors & Fragrances
IFF
$19.4B
$3.21M 1.63%
37,277
+11,341
+44% +$911K
ROP icon
28
Roper Technologies
ROP
$36.3B
$3.2M 1.63%
5,699
-9
-0.2% -$4.91K
TMO icon
29
Thermo Fisher Scientific
TMO
$211B
$3.19M 1.62%
5,487
-159
-3% -$89.2K
BKNG icon
30
Booking.com
BKNG
$138B
$3.19M 1.62%
21,950
-1,375
-6% -$196K
UL icon
31
Unilever
UL
$131B
$3.15M 1.6%
55,756
+11,208
+25% +$621K
ABT icon
32
Abbott
ABT
$180B
$3.14M 1.6%
27,664
-3,559
-11% -$408K
RTX icon
33
RTX Corp
RTX
$287B
$3.11M 1.58%
31,877
-1,573
-5% -$142K
EA icon
34
Electronic Arts
EA
$52.4B
$3.11M 1.58%
23,431
-405
-2% -$55.6K
BDX icon
35
Becton Dickinson
BDX
$43.1B
$3.09M 1.57%
12,473
+949
+8% +$227K
MSFT icon
36
Microsoft
MSFT
$2.84T
$3.08M 1.57%
7,330
-7,306
-50% -$2.96M
MDT icon
37
Medtronic
MDT
$107B
$3.06M 1.56%
35,118
+27,472
+359% +$2.34M
PM icon
38
Philip Morris
PM
$301B
$3.06M 1.56%
33,404
+13,056
+64% +$1.2M
TKO icon
39
TKO Group
TKO
$13.5B
$3.06M 1.56%
35,397
+1,191
+3% +$99.1K
BTI icon
40
British American Tobacco
BTI
$132B
$3.04M 1.55%
+99,784
New +$3M
KO icon
41
Coca-Cola
KO
$354B
$3.03M 1.55%
49,596
+8,403
+20% +$505K
GOOGL icon
42
Alphabet (Google) Class A
GOOGL
$3.91T
$3.03M 1.54%
20,087
-4,434
-18% -$634K
JNJ icon
43
Johnson & Johnson
JNJ
$635B
$2.99M 1.52%
18,923
+4,930
+35% +$785K
SPGI icon
44
S&P Global
SPGI
$126B
$2.98M 1.52%
7,015
-456
-6% -$198K
FOX icon
45
Fox Class B
FOX
$20.7B
$2.95M 1.5%
103,009
+101,254
+5,769% +$2.83M
SBUX icon
46
Starbucks
SBUX
$118B
$2.91M 1.48%
31,821
+10,542
+50% +$981K
NVS icon
47
Novartis
NVS
$295B
$2.87M 1.46%
29,649
ACN icon
48
Accenture
ACN
$89.9B
$2.82M 1.43%
8,130
-1,749
-18% -$637K
CHRW icon
49
C.H. Robinson
CHRW
$22B
$2.76M 1.41%
36,280
+25,653
+241% +$2.01M
AAPL icon
50
Apple
AAPL
$4.89T
$2.74M 1.4%
15,977
-12,011
-43% -$2.18M

Similar funds

Arlington Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Arlington Partners held 261 positions worth $196M, down 44% from $348M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Arlington Partners withdrew a net $164M in Q1 2024, closing 201 positions and reducing 26 holdings. Its most notable exit was Vanguard High Dividend Yield ETF, an estimated $40.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Arlington Partners opened a new position in Palmer Square Capital BDC worth $6.08M.

  • Arlington Partners's largest Q1 2024 buy was Palmer Square Capital BDC: 373,006 shares worth $6.08M.
  • Arlington Partners added most to Bristol-Myers Squibb in Q1 2024, an estimated $3.08M increase.
  • Arlington Partners's biggest Q1 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.23M.
  • Arlington Partners fully exited Vanguard High Dividend Yield ETF in Q1 2024, selling an estimated $40.4M.
  • Arlington Partners's ten largest holdings make up 27% of its $196M portfolio in Q1 2024.
  • Arlington Partners opened 5 new positions and closed 201 in Q1 2024.
  • Arlington Partners's portfolio value fell 44% quarter-over-quarter to $196M.

Based on Arlington Partners's 13F filing for Q1 2024, filed 16 Apr 2024.